These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27397077)

  • 1. BAFF is decreased in the cerebrospinal fluid of multiple sclerosis at clinical onset.
    Puthenparampil M; Miante S; Federle L; Zanetta C; Toffanin E; Ruggero S; Rinaldi F; Gallo P
    J Neuroimmunol; 2016 Aug; 297():63-7. PubMed ID: 27397077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset.
    Puthenparampil M; Federle L; Miante S; Zito A; Toffanin E; Ruggero S; Ermani M; Pravato S; Poggiali D; Perini P; Rinaldi F; Gallo P
    J Neuroinflammation; 2017 Jan; 14(1):11. PubMed ID: 28095856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal K free light chain synthesis in multiple sclerosis at clinical onset associates with local IgG production and improves the diagnostic value of cerebrospinal fluid examination.
    Puthenparampil M; Altinier S; Stropparo E; Zywicki S; Poggiali D; Cazzola C; Toffanin E; Ruggero S; Grassivaro F; Zaninotto M; Plebani M; Gallo P
    Mult Scler Relat Disord; 2018 Oct; 25():241-245. PubMed ID: 30130707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid CXCL13 in clinically isolated syndrome patients: Association with oligoclonal IgM bands and prediction of Multiple Sclerosis diagnosis.
    Ferraro D; Galli V; Vitetta F; Simone AM; Bedin R; Del Giovane C; Morselli F; Filippini MM; Nichelli PF; Sola P
    J Neuroimmunol; 2015 Jun; 283():64-9. PubMed ID: 26004159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal BAFF and Epstein-Barr virus-specific oligoclonal bands in multiple sclerosis and other inflammatory demyelinating neurological diseases.
    Franciotta D; Di Stefano AL; Jarius S; Zardini E; Tavazzi E; Ballerini C; Marchioni E; Bergamaschi R; Ceroni M
    J Neuroimmunol; 2011 Jan; 230(1-2):160-3. PubMed ID: 21109310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid.
    Ragheb S; Li Y; Simon K; VanHaerents S; Galimberti D; De Riz M; Fenoglio C; Scarpini E; Lisak R
    Mult Scler; 2011 Jul; 17(7):819-29. PubMed ID: 21372118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of B-cell activating factor in serum and cerebrospinal fluid of patients with neuromyelitis optical].
    Yang F; Huang D; Wu W
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Mar; 35(3):380-3. PubMed ID: 25818784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAFF serum and CSF levels in patients with multiple sclerosis and infectious nervous system diseases.
    Braun T; Juenemann M; Dornes K; El-Shazly J; Schramm P; Bick-Ackerschott S; Kaps M; Gerriets T; Blaes F; Tschernatsch M
    Int J Neurosci; 2021 Dec; 131(12):1231-1236. PubMed ID: 32602764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid BAFF and APRIL levels in neuromyelitis optica and multiple sclerosis patients during relapse.
    Wang H; Wang K; Zhong X; Qiu W; Dai Y; Wu A; Hu X
    J Clin Immunol; 2012 Oct; 32(5):1007-11. PubMed ID: 22644841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis.
    Jarius S; König FB; Metz I; Ruprecht K; Paul F; Brück W; Wildemann B
    J Neuroinflammation; 2017 Aug; 14(1):171. PubMed ID: 28851393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MS and clinically isolated syndromes: shared specificity but diverging clonal patterns of virus-specific IgG antibodies produced in vivo and by CSF B cells in vitro.
    Skorstad G; Vandvik B; Vartdal F; Holmøy T
    Eur J Neurol; 2009 Oct; 16(10):1124-9. PubMed ID: 19469834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study.
    Olesen MN; Soelberg K; Debrabant B; Nilsson AC; Lillevang ST; Grauslund J; Brandslund I; Madsen JS; Paul F; Smith TJ; Jarius S; Asgari N
    J Neuroinflammation; 2019 Mar; 16(1):59. PubMed ID: 30857557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution.
    Beseler C; Vollmer T; Graner M; Yu X
    PLoS One; 2017; 12(10):e0186842. PubMed ID: 29059249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paediatric and adult multiple sclerosis: age-related differences and time course of the neuroimmunological response in cerebrospinal fluid.
    Reiber H; Teut M; Pohl D; Rostasy KM; Hanefeld F
    Mult Scler; 2009 Dec; 15(12):1466-80. PubMed ID: 19995844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential increase of B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica in a white population.
    Vaknin-Dembinsky A; Brill L; Orpaz N; Abramsky O; Karussis D
    Mult Scler; 2010 Dec; 16(12):1453-7. PubMed ID: 20935029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis.
    Piazza F; DiFrancesco JC; Fusco ML; Corti D; Pirovano L; Frigeni B; Mattavelli L; Andreoni S; Frigo M; Ferrarese C; Tredici G; Cavaletti G
    J Neuroimmunol; 2010 Mar; 220(1-2):104-7. PubMed ID: 20149932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis.
    Axelsson M; Mattsson N; Malmeström C; Zetterberg H; Lycke J
    J Neuroimmunol; 2013 Nov; 264(1-2):100-5. PubMed ID: 24125567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
    Link H; Huang YM
    J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The predictive value of CSF multiple assay in multiple sclerosis: A single center experience.
    De Fino C; Lucchini M; Lucchetti D; Nociti V; Losavio FA; Bianco A; Colella F; Ricciardi-Tenore C; Sgambato A; Mirabella M
    Mult Scler Relat Disord; 2019 Oct; 35():176-181. PubMed ID: 31394405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis.
    Villar LM; Masterman T; Casanova B; Gómez-Rial J; Espiño M; Sádaba MC; González-Porqué P; Coret F; Alvarez-Cermeño JC
    J Neuroimmunol; 2009 Jun; 211(1-2):101-4. PubMed ID: 19443047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.